Personalized treatment of malignant tumours according to Ki67
Nuclear protein Ki67 suitable as a biomarker for pleural mesothelioma. International study by Karl Landsteiner University of Health Sciences confirms Ki67’s high informative value for tumour aggressiveness and surgical treatment success. Therapy individualization possible. Krems (Austria), 26. June 2024: The nuclear protein Ki67 is a meaningful biomarker for tumour aggressiveness and for the success of […]